Non-Hallucinogenic Psilocybin & Mental Health: Diamond Therapeutics’ Historic Clinical Trial Begins Nov 24, 2021
Synthesized Non-Hallucinogenic LSD Puts BetterLife Pharma on Psychedelic Investors Radar Nov 18, 2021
MindMed Announces Financial Results for the Third Quarter 2021 and Business Highlights; Cash Balance of $145.9 USD… Nov 15, 2021
COMPASS Pathways plc announces financial results and business highlights for the third quarter 2021 Nov 9, 2021
Delic Completes Acquisition of Ketamine Wellness Centers (KWC), Becomes Largest Psychedelic Wellness Chain in United… Nov 9, 2021
Awakn Life Sciences Announces the Findings from the Phase II A/B Study Are to Be Published in the American Journal of… Nov 4, 2021
